HLN Company Profile and Key Details

Haleon plc (NYSE:HLN) closed at $9.03 USD, losing -$0.05 (-0.55%) from the previous close of $9.08. The stock is currently within 5% of its 52-week low $8.65 and $11.28. With a market capitalization of about $39.94 billion, Haleon plc is classified as a large-cap and shows lower-than-market volatility (beta ~0.25). Key stats such as the average daily volume over the past year has been around 8.66 million shares, in line with its 52-week average. Headquartered in Weybridge, None, Haleon plc operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Brian James McNamara, the company employs approximately 24,561 people and listed since July 25, 2022. Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods.

Short-term trend indicators are bearishly aligned (SMA20 -1.32%, SMA50 3.52%, SMA200 7.98%). The stock’s 14-day RSI is 50.32 (neutral), while the ATR of 0.24 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -5.78% below its high and over 23.54% above its low. Average 10-day trading volume of 10.36 million shares is slightly above the 3-month average of 8.61 million, indicating heightened recent market interest.

Haleon plc trades at a P/E ratio of 10.83, slightly below the S&P 500 average, with a price-to-sales ratio of 1.55 and a price-to-book ratio of 1.84 suggesting the stock is closer to book value. The P/FCF stands at 13.06, also above market averages.

Haleon plc last paid a dividend of 0.19 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $22.06. This means the shares are trading below this model’s fair value.

Haleon plc generated EPS of $0.43 over the past year. Five-year average earnings growth is 17.4%. Wall Street analysts project EPS growth of 9.26% annually over the next five years. The latest quarter delivered EPS of $0.26. The next quarter is forecast at $0.13. Next year's EPS is expected at $7.78. Haleon plc earnings surprise history is a mixed track record. The quarter that ended February 25, 2026, missed forecasts by 3.38%. The prior quarter beat by -42.83%. Over the last six quarters, Apple has recorded several small beats. These include -11.11% in August 01, 2024.

Haleon plc has 4.48 billion shares outstanding. The public float is 8.95 billion shares, elevated short interest at 0.39% of float. This equals 17.45 million shares. The short ratio is 1.39 days. Institutional investors hold 12.85% of the float. Insiders own 0.02%.

Our AI price prediction model suggests that Haleon plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.66%, with price expected at $8.88 by June 25, 2026, within a range of $8.72 to $9.05 3-Month Outlook: Projected fall of -12.85%, reaching $7.87 by September 08, 2026, with a range of $7.47 to $8.21. 1-Year Outlook: Projected gain of 122.04%, with price at $20.05 by June 11, 2027, within a range of $10.06 to $28.29.

Haleon plc (NYSE:HLN) shares are flat 0.2% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Haleon plc trading at a premium to the broader market with a P/E of 10.83. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $10.47, suggesting 15.95% upside. Our AI forecast model points to short-term weakness (-1.66% over two weeks), a medium-term fall (-12.85% over three months), and a longer-term gain (122.04% over one year), with expected trading ranges indicating moderate volatility.